C. Fenoglio

发表

Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration

N. Bresolin, C. Mariani, D. Galimberti, 2007, Neuroscience Letters.

Epigenetic regulatory modifications in genetic and sporadic frontotemporal dementia

D. Galimberti, C. Fenoglio, E. Scarpini, 2018, Expert review of neurotherapeutics.

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

Nick C Fox, Cory C. Funk, D. G. Clark, 2017, Nature Genetics.

Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study

Veronica Redaelli, Sebastien Ourselin, Martina Bocchetta, 2019, Brain : a journal of neurology.

MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer’s Disease

D. Galimberti, C. Fenoglio, E. Scarpini, 2020, Cells.

Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

D. G. Clark, M. Fornage, A. Hofman, 2018, Alzheimer's & dementia.

Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2019, The Lancet Neurology.

Neurofilament light chain: a biomarker for genetic frontotemporal dementia

S. Ourselin, S. Rombouts, M. Rossor, 2016, Annals of clinical and translational neurology.

A Trans-Specific Polymorphism in ZC3HAV1 Is Maintained by Long-Standing Balancing Selection and May Confer Susceptibility to Multiple Sclerosis

N. Bresolin, A. Goris, D. Galimberti, 2012, Molecular biology and evolution.

White Matter Hyperintensities Are No Major Confounder for Alzheimer’s Disease Cerebrospinal Fluid Biomarkers

Linda J. C. van Waalwijk van Doorn, G. Frisoni, H. Soininen, 2020, Journal of Alzheimer's disease : JAD.

Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

Nick C Fox, Alan J. Thomas, D. Hernandez, 2020, Scientific Reports.

PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population.

D. Mari, S. Sorbi, C. Mariani, 2016, Journal of Alzheimer's disease : JAD.

Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis.

D. Galimberti, C. Fenoglio, E. Scarpini, 2019, Multiple sclerosis and related disorders.

Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes

M. Bozzali, D. Galimberti, C. Fenoglio, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis

D. Galimberti, C. Fenoglio, E. Scarpini, 2022, Cells.

Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline.

G. Cappellano, A. Chiocchetti, U. Dianzani, 2010, Journal of Alzheimer's disease : JAD.

A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia

N. Bresolin, S. Cappa, D. Galimberti, 2011, Alzheimer's & Dementia.

A second major histocompatibility complex susceptibility locus for multiple sclerosis

Stephan Beck, Roger Horton, Stephen L Hauser, 2007, Annals of neurology.

Frontotemporal Dementia Misdiagnosed for Post-Treatment Lyme Disease Syndrome or vice versa? A Treviso Dementia (TREDEM) Registry Case Report.

D. Galimberti, C. Fenoglio, M. D. Di Battista, 2018, Journal of Alzheimer's disease : JAD.

Profiling of Ubiquitination Pathway Genes in Peripheral Cells from Patients with Frontotemporal Dementia due to C9ORF72 and GRN Mutations

D. Galimberti, C. Fenoglio, E. Scarpini, 2015, International journal of molecular sciences.

Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred.

N. Bresolin, D. Galimberti, C. Fenoglio, 2011, Journal of Alzheimer's disease : JAD.

Is KIF24 a genetic risk factor for Frontotemporal Lobar Degeneration?

N. Bresolin, S. Cappa, M. Franceschi, 2010, Neuroscience Letters.

Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration

N. Bresolin, S. Cappa, F. Clerici, 2007, European journal of neurology.

White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2019, NeuroImage: Clinical.

Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy

D. Galimberti, C. Fenoglio, P. Lehenkari, 2018, Journal of cellular and molecular medicine.

Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.

Linda J. C. van Waalwijk van Doorn, K. Blennow, J. Molinuevo, 2017, Journal of Alzheimer's disease : JAD.

Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes.

D. Galimberti, C. Fenoglio, E. Scarpini, 2016, Journal of Alzheimer's disease : JAD.

Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations and C9orf72 repeat expansions

S. Rivaud-Pechoux, D. Galimberti, C. Fenoglio, 2014, Neurobiology of Aging.

No major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohort

N. Bresolin, G. Comi, S. Corti, 2011, Neurobiology of Aging.

The functional MAOA‐uVNTR promoter polymorphism in patients with frontotemporal dementia

K. Lesch, D. Galimberti, C. Fenoglio, 2008, European journal of neurology.

Overlap Between Frontotemporal Dementia and Dementia with Lewy Bodies: A Treviso Dementia (TREDEM) Registry Case Report.

D. Galimberti, C. Fenoglio, M. D. Di Battista, 2019, Journal of Alzheimer's disease : JAD.

GRN Thr272fs clinical heterogeneity: a case with atypical late onset presenting with a dementia with Lewy bodies phenotype.

D. Mari, D. Galimberti, C. Fenoglio, 2013, Journal of Alzheimer's disease : JAD.

Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study

D. Galimberti, M. Bocchetta, J. Rohrer, 2018, Neurobiology of Aging.

Progranulin as a therapeutic target for dementia

D. Galimberti, C. Fenoglio, E. Scarpini, 2018, Expert opinion on therapeutic targets.

Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation.

D. Galimberti, C. Fenoglio, E. Scarpini, 2016, Journal of Alzheimer's disease : JAD.

Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients

D. Galimberti, C. Fenoglio, E. Scarpini, 2022, Cells.

CCL8/MCP-2 association analysis in patients with Alzheimer’s disease and frontotemporal lobar degeneration

N. Bresolin, S. Cappa, F. Clerici, 2009, Journal of Neurology.

Binge eating and fast cognitive worsening in an early-onset bvFTD patient carrying C9ORF72 expansion

D. Galimberti, C. Fenoglio, E. Scarpini, 2015, Neurocase.

The CST3 B haplotype is associated with frontotemporal lobar degeneration

G. Frisoni, G. Frisoni, D. Galimberti, 2010, European journal of neurology.

CSF β-amyloid and white matter damage: a new perspective on Alzheimer’s disease

Giovanni Giulietti, Marco Bozzali, Alberto Calvi, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

Inflammatory molecules in Frontotemporal Dementia: Cerebrospinal fluid signature of progranulin mutation carriers

D. Galimberti, C. Fenoglio, E. Scarpini, 2015, Brain, Behavior, and Immunity.

Modulation of RAS and PI3-AKT pathway by Stavudine (d4T) in PBMC of Alzheimer’s Disease Patients

D. Galimberti, C. Fenoglio, E. Scarpini, 2020 .

CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease.

N. Bresolin, C. Mariani, D. Galimberti, 2004, Journal of Neurological Sciences.

Incomplete penetrance of the C9ORF72 hexanucleotide repeat expansions: frequency in a cohort of geriatric non-demented subjects.

D. Mari, D. Galimberti, C. Fenoglio, 2014, Journal of Alzheimer's disease : JAD.

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia.

Nick C. Fox, Pietro Pietrini, Alexander Gerhard, 2018, Nature Medicine.

Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation

F. Turkheimer, D. Galimberti, C. Fenoglio, 2022, Alzheimer's Research & Therapy.

Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

M. Nalls, A. Ramasamy, P. Pietrini, 2019, Scientific Reports.

Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia

G. Comi, S. Corti, J. Landers, 2013, Neurobiology of Aging.

Novel evidence of phenotypical variability in the hexanucleotide repeat expansion in chromosome 9.

S. Cappa, D. Galimberti, C. Fenoglio, 2013, Journal of Alzheimer's disease : JAD.

GRN variability contributes to sporadic frontotemporal lobar degeneration.

N. Bresolin, S. Cappa, F. Clerici, 2010, Journal of Alzheimer's disease : JAD.

miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia

D. Galimberti, C. Fenoglio, M. Serpente, 2022, International journal of molecular sciences.

The C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia

D. Galimberti, C. Fenoglio, E. Scarpini, 2014, Neurobiology of Aging.

Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations.

N. Bresolin, D. Galimberti, C. Fenoglio, 2012, Journal of Alzheimer's disease : JAD.

Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2022, Journal of Neuroinflammation.

Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia.

S. Cappa, D. Galimberti, C. Fenoglio, 2013, Journal of Alzheimer's disease : JAD.

IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment

D. Galimberti, C. Fenoglio, E. Scarpini, 2020, Journal of Neuroinflammation.

2019IL-33 and its decoy sST2 in patients with Alzheimer’s Disease and Mild Cognitive Impairment

D. Galimberti, C. Fenoglio, E. Scarpini, 2019 .

Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations

Jennifer M. Nicholas, P. Thompson, R. Keren, 2022, Journal of Neurology.

The CBI‐R detects early behavioural impairment in genetic frontotemporal dementia

Nick C Fox, M. Freedman, S. Ourselin, 2022, Annals of clinical and translational neurology.

The novel GRN g.1159_1160delTG mutation is associated with behavioral variant frontotemporal dementia.

D. Galimberti, C. Fenoglio, E. Scarpini, 2015, Journal of Alzheimer's disease : JAD.

Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation

D. Galimberti, C. Fenoglio, E. Scarpini, 2017, Neurology.

Temporal order of clinical and biomarker changes in familial frontotemporal dementia

Jennifer M. Nicholas, Sheng-Yang M. Goh, M. Freedman, 2022, Nature Medicine.

Monozygotic Twins with Frontotemporal Dementia Due To Thr272fs GRN Mutation Discordant for Age At Onset.

D. Galimberti, C. Fenoglio, E. Scarpini, 2019, Journal of Alzheimer's disease : JAD.

Evidence of pre-synaptic dopaminergic deficit in a patient with a novel progranulin mutation presenting with atypical parkinsonism.

D. Galimberti, C. Fenoglio, E. Scarpini, 2013, Journal of Alzheimer's disease : JAD.

A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease

D. Galimberti, C. Fenoglio, E. Scarpini, 2022, Biomedicines.

C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder

A. Altamura, D. Galimberti, C. Fenoglio, 2014, Bipolar disorders.

C9ORF72 hexanucleotide repeat expansion frequency in patients with Paget's disease of bone

D. Galimberti, C. Fenoglio, E. Scarpini, 2020, Neurobiology of Aging.

CIRCULATING AND INTRATHECAL MIRNAS AS POTENTIAL BIOMARKERS FOR ALZHEIMER'S DISEASE

D. Galimberti, C. Fenoglio, E. Scarpini, 2014, Alzheimer's & Dementia.

Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis

A. Bianchi, D. Galimberti, C. Fenoglio, 2022, European Radiology.

Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms

C. Fenoglio, F. Guerini, C. Agliardi, 2023, Neurobiology of Disease.

GENFI - The GENetic Frontotemporal dementia Initiative

M. Freedman, R. Keren, G. Frisoni, 2012 .

CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis.

D. Galimberti, C. Fenoglio, E. Scarpini, 2019, Multiple sclerosis and related disorders.

CSF β-amyloid predicts prognosis in patients with multiple sclerosis

M. Bozzali, D. Galimberti, C. Fenoglio, 2018, Multiple sclerosis.

Usefulness of Multi-Parametric MRI for the Investigation of Posterior Cortical Atrophy

N. Bresolin, M. Bozzali, D. Galimberti, 2015, PloS one.

Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect

Arosio, D. Galimberti, C. Fenoglio, 2023, GeroScience.

Progranulin Gene Variability and Plasma Levels in Bipolar Disorder and Schizophrenia

N. Bresolin, A. Altamura, D. Galimberti, 2012, PloS one.

Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis

N. Bresolin, U. Dianzani, D. Galimberti, 2008, Journal of the Neurological Sciences.

MDC/CCL22 intrathecal levels in patients with multiple sclerosis

N. Bresolin, D. Galimberti, C. Fenoglio, 2008, Multiple sclerosis.

Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation.

R. Schmidt, D. Galimberti, C. Fenoglio, 2008, Brain : a journal of neurology.

Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer’s Disease and Frontotemporal Dementia1

D. Galimberti, C. Fenoglio, E. Scarpini, 2018, Journal of Alzheimer's disease : JAD.

Genetics and Epigenetics in the Neurodegenerative Disorders of the Central Nervous System

C. Fenoglio, 2018 .

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Nick C Fox, Catherine A. Macleod, W. M. van der Flier, 2022, Nature Genetics.

Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

W. M. van der Flier, M. Fornage, D. Rujescu, 2021, Nature Communications.

Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid

D. Galimberti, C. Fenoglio, E. Scarpini, 2011, Multiple sclerosis.

MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers

V. Martinelli, G. Comi, D. Galimberti, 2012, Neuroscience Letters.

Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis

N. Bresolin, D. Galimberti, C. Fenoglio, 2011, Neuroscience Letters.

CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course

N. Bresolin, C. Mariani, D. Galimberti, 2007, European journal of neurology.

A Functional Variant in ERAP1 Predisposes to Multiple Sclerosis

N. Bresolin, G. Comi, D. Galimberti, 2012, PloS one.

Exploring the role of BDNF DNA methylation and hydroxymethylation in patients with obsessive compulsive disorder.

D. Galimberti, C. Fenoglio, E. Scarpini, 2019, Journal of psychiatric research.

Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients.

A. Altamura, D. Galimberti, C. Fenoglio, 2014, Journal of affective disorders.

Selective DNA Methylation of BDNF Promoter in Bipolar Disorder: Differences Among Patients with BDI and BDII

N. Bresolin, D. Mari, A. Altamura, 2012, Neuropsychopharmacology.

Extracellular Vesicles in Multiple Sclerosis: Role in the Pathogenesis and Potential Usefulness as Biomarkers and Therapeutic Tools

D. Galimberti, C. Fenoglio, E. Scarpini, 2021, Cells.

Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study

D. Galimberti, C. Fenoglio, E. Scarpini, 2020, Neurological Sciences.

Repetitive element hypermethylation in multiple sclerosis patients

D. Galimberti, C. Fenoglio, E. Scarpini, 2016, BMC Genetics.

MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis

D. Galimberti, C. Fenoglio, E. Scarpini, 2012, International journal of molecular sciences.

Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis

N. Bresolin, D. Galimberti, C. Fenoglio, 2007, Neuroscience Letters.

Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort

G. Comi, C. Fenoglio, D. Scalabrini, 2010, European journal of neurology.

SORL1 Gene is Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.

Gianluigi Forloni, Giuseppe Tosto, Paola Piscopo, 2015, Journal of Alzheimer's disease : JAD.

Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status

A. Fagan, D. Holtzman, C. Cruchaga, 2016, Acta Neuropathologica.

Regulation of gene transcription in bipolar disorders: Role of DNA methylation in the relationship between prodynorphin and brain derived neurotrophic factor

A. Altamura, D. Galimberti, C. Fenoglio, 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

Nick C Fox, Alan J. Thomas, D. Hernandez, 2021, Biological Psychiatry.

Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia

D. Galimberti, C. Fenoglio, E. Scarpini, 2022, International journal of molecular sciences.

An Emerging Role for Long Non-Coding RNA Dysregulation in Neurological Disorders

D. Galimberti, C. Fenoglio, E. Scarpini, 2013, International journal of molecular sciences.

Repetitive element hypermethylation in multiple sclerosis patients

D. Galimberti, C. Fenoglio, E. Scarpini, 2016, BMC Genetics.

Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition

A. Fagan, J. Morris, D. Holtzman, 2008, Proceedings of the National Academy of Sciences.

Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study

Jennifer M. Nicholas, M. Freedman, N. Fox, 2021, Alzheimer's & dementia.

Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2020, Cortex.

Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes

N. Bresolin, D. Galimberti, C. Fenoglio, 2010, Neuroscience Letters.

Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay

Nick C Fox, J. Schott, N. Sebire, 2015, Molecular Neurodegeneration.

SELPLG and SELP single-nucleotide polymorphisms in multiple sclerosis

N. Bresolin, M. Ban, A. Goris, 2006, Neuroscience Letters.

New insights on the genetic etiology of Alzheimer’s and related dementia

Nick C Fox, Catherine A. Macleod, W. M. van der Flier, 2020 .

Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease

N. Bresolin, F. Clerici, D. Galimberti, 2006, Neurobiology of Aging.

MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels

N. Bresolin, C. Mariani, D. Galimberti, 2004, Neurobiology of Aging.

Association of a NOS1 promoter repeat with Alzheimer's disease

Alexander Strobel, Ilaria Guidi, Klaus-Peter Lesch, 2008, Neurobiology of Aging.

across RNA cell death gene networks is implicated in the semantic variant of primary progressive aphasia.

L. Ferrucci, A. Ramasamy, E. Haan, 2019 .

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

E. Haan, P. Pietrini, R. Petersen, 2017, Scientific Reports.

D. Hernandez, M. Nalls, L. Ferrucci, 2017, bioRxiv.

Heterozygous TREM2 mutations in frontotemporal dementia

S. Sorbi, B. Nacmias, D. Galimberti, 2014, Neurobiology of Aging.

Frontotemporal dementia and its subtypes: a genome-wide association study

Alexander Gerhard, Adrian Danek, Luigi Ferrucci, 2014, The Lancet Neurology.

Gene promoter methylation and expression of Pin1 differ between patients with frontotemporal dementia and Alzheimer's disease

D. Mari, D. Galimberti, C. Fenoglio, 2016, Journal of the Neurological Sciences.

Recognition of viral and self‐antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses

D. Galimberti, C. Fenoglio, E. Scarpini, 2017, The Journal of allergy and clinical immunology.

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery

D. Galimberti, C. Fenoglio, E. Scarpini, 2021, Antioxidants.

ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution

Elisa Cerutti, A. Chiocchetti, U. Dianzani, 2007, Journal of Neuroimmunology.

LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients

A. Goris, D. Galimberti, C. Fenoglio, 2018, Journal of Neuroimmunology.

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

S. Rauch, C. Enzinger, X. Montalban, 2015, Multiple sclerosis.

Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration

N. Bresolin, D. Galimberti, C. Fenoglio, 2008, Journal of Neurology.

CLIC1 Protein Accumulates in Circulating Monocyte Membrane during Neurodegeneration

D. Galimberti, C. Fenoglio, M. Mazzanti, 2020, International journal of molecular sciences.

Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.

D. Galimberti, C. Fenoglio, E. Scarpini, 2016, Journal of Alzheimer's disease : JAD.

Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration.

N. Bresolin, S. Cappa, M. Franceschi, 2011, Rejuvenation Research.

Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysis.

N. Bresolin, S. Cappa, M. Franceschi, 2011, Journal of Alzheimer's disease : JAD.

Inflammation in neurodegenerative disorders: friend or foe?

D. Galimberti, C. Fenoglio, E. Scarpini, 2008, Current aging science.

A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2021, Brain : a journal of neurology.

Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis

N. Bresolin, G. Comi, D. Galimberti, 2006, Neurobiology of Aging.

Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease

N. Bresolin, D. Galimberti, C. Fenoglio, 2006, Neurobiology of Aging.

IP‐10 serum levels are not increased in mild cognitive impairment and Alzheimer's disease

N. Bresolin, C. Mariani, D. Galimberti, 2007, European journal of neurology.

Candidate gene analysis of IP-10 gene in patients with Alzheimer's disease

N. Bresolin, F. Clerici, C. Mariani, 2006, Neuroscience Letters.

Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis

P. Kloetzel, M. Stumpf, A. Chiocchetti, 2017, Scientific Reports.

Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2019, Neurobiology of Aging.

C9ORF72 repeat expansion not detected in patients with multiple sclerosis

D. Galimberti, C. Fenoglio, E. Scarpini, 2014, Neurobiology of Aging.

Preliminary evidence that VEGF genetic variability confers susceptibility to frontotemporal lobar degeneration.

N. Bresolin, G. Comi, M. Luca, 2008, Rejuvenation research.

BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease.

N. Bresolin, S. Cappa, M. Franceschi, 2011, Journal of Alzheimer's disease : JAD.

Circular RNAs: Emblematic Players of Neurogenesis and Neurodegeneration

D. Galimberti, C. Fenoglio, M. D’Anca, 2022, International journal of molecular sciences.

Exosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases

M. Cesari, D. Galimberti, C. Fenoglio, 2019, Front. Aging Neurosci..

CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia

D. Galimberti, J. Rohrer, C. Fenoglio, 2018, Neurobiology of Aging.

Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration

N. Bresolin, Y. Pijnenburg, D. Galimberti, 2006, Neurology.

CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients.

M. Franceschi, G. Comi, G. Magnani, 2016, Journal of Alzheimer's disease : JAD.

Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales

Nick C Fox, M. Freedman, S. Ourselin, 2018, Alzheimer's research & therapy.

Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

Jennifer M. Nicholas, M. Freedman, R. Keren, 2022, Journal of Neurology.

APOE ε2 and ε4 influence the susceptibility for Alzheimer's disease but not other dementias.

F. Clerici, C. Mariani, D. Galimberti, 2010, International journal of molecular epidemiology and genetics.

Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

M. Freedman, J. Dukart, R. Keren, 2023, Neurobiology of Disease.

Phenotypic variability associated with the C9ORF72 hexanucleotide repeat expansion: a sporadic case of frontotemporal lobar degeneration with prodromal hyposmia and predominant semantic deficits.

D. Mari, D. Galimberti, C. Fenoglio, 2014, Journal of Alzheimer's disease : JAD.

Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation

G. Comi, S. Cappa, M. Filippi, 2013, Biological Psychiatry.

Lag-time in Alzheimer’s disease patients: a potential plasmatic oxidative stress marker associated with ApoE4 isoform

D. Galimberti, C. Fenoglio, E. Galliera, 2019, Immunity & Ageing.

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2020, NeuroImage: Clinical.

GSK3β genetic variability in patients with Multiple Sclerosis

D. Comings, N. Bresolin, D. Galimberti, 2011, Neuroscience Letters.

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2017, Nature Communications.

Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis

N. Bresolin, D. Galimberti, C. Fenoglio, 2013, Multiple sclerosis.

E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis

N. Bresolin, D. Galimberti, C. Fenoglio, 2005, Journal of Neuroimmunology.

Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort

J. E. Iglesias, Jennifer M. Nicholas, M. Freedman, 2023, Brain communications.

Differential early subcortical involvement in genetic FTD within the GENFI cohort

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2021, NeuroImage: Clinical.

Candidate gene analysis of selectin cluster in patients with multiple sclerosis

N. Bresolin, D. Galimberti, C. Fenoglio, 2009, Journal of Neurology.

Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease.

S. Cappa, M. Franceschi, F. Clerici, 2013, Journal of Alzheimer's disease : JAD.

Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis

D. Galimberti, C. Fenoglio, E. Scarpini, 2016, Multiple sclerosis.

Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males

N. Bresolin, G. Comi, D. Galimberti, 2010, Genes and Immunity.

A Case with Early Onset Alzheimer's Disease, Frontotemporal Hypometabolism, ApoE Genotype ɛ4/ɛ4 and C9ORF72 Intermediate Expansion: A Treviso Dementia (TREDEM) Registry Case Report.

D. Galimberti, C. Fenoglio, M. Gregianin, 2019, Journal of Alzheimer's disease : JAD.

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia.

Nick C Fox, Alan J. Thomas, D. Hernandez, 2018, Nature Medicine.

Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer’s disease

N. Bresolin, F. Clerici, C. Mariani, 2011, Journal of Neurology.

Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease?

D. Galimberti, C. Fenoglio, E. Scarpini, 2021, Journal of Alzheimer's disease : JAD.

Progranulin gene variability influences the risk for bipolar I disorder, but not bipolar II disorder.

A. Altamura, D. Galimberti, C. Fenoglio, 2014, Bipolar disorders.

A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

Nick C Fox, Alan J. Thomas, D. Hernandez, 2018, Brain : a journal of neurology.

Circulating miRNAs as potential biomarkers in Alzheimer's disease.

D. Galimberti, C. Fenoglio, E. Scarpini, 2014, Journal of Alzheimer's disease : JAD.

Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration.

N. Bresolin, S. Cappa, M. Franceschi, 2012, Journal of Alzheimer's Disease.

MCP-1 A-2518G polymorphism: effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels.

N. Bresolin, S. Cappa, F. Clerici, 2009, Journal of Alzheimer's disease : JAD.

Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study.

D. Galimberti, C. Fenoglio, E. Scarpini, 2023, Journal of Alzheimer's disease : JAD.

Late‐onset presentation and phenotypic heterogeneity of the rare R377W PSEN1 mutation

Y. Pijnenburg, D. Galimberti, C. Fenoglio, 2020, European journal of neurology.

Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.

N. Bresolin, A. Goate, K. Mayo, 2009, Journal of Alzheimer's disease : JAD.

Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.

N. Bresolin, P. Scheltens, F. Bouwman, 2006, Archives of neurology.

TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease

D. Galimberti, C. Fenoglio, E. Scarpini, 2023, International journal of molecular sciences.

Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu‐Hakola Disease

D. Galimberti, C. Fenoglio, L. Piccio, 2019, Cytokine.

Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease

D. Galimberti, C. Fenoglio, E. Scarpini, 2021, Pharmaceuticals.

Unravelling the Association Between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer’s Disease Spectrum: Who Really Deserves an A+?

D. Galimberti, C. Fenoglio, E. Scarpini, 2021, Journal of Alzheimer's Disease.

The progranulin (GRN) Cys157LysfsX97 mutation is associated with nonfluent variant of primary progressive aphasia clinical phenotype.

M. Filippi, F. Agosta, M. Falautano, 2012, Journal of Alzheimer's disease : JAD.

Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes

D. Galimberti, C. Fenoglio, E. Scarpini, 2019, Alzheimer's Research & Therapy.

CCR2-64I polymorphism and CCR5Δ32 deletion in patients with Alzheimer's disease

N. Bresolin, C. Mariani, D. Galimberti, 2004, Journal of the Neurological Sciences.

Cerebrospinal fluid biomarkers in Progranulin mutations carriers.

N. Bresolin, M. Franceschi, D. Galimberti, 2011, Journal of Alzheimer's disease : JAD.

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

Nick C Fox, D. Hernandez, M. Nalls, 2017, Scientific Reports.

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis

M. Bozzali, D. Galimberti, C. Fenoglio, 2017, Multiple sclerosis.

More Atypical than Atypical Alzheimer’s Disease Phenotypes: A Treviso Dementia (TREDEM) Registry Case Report

D. Galimberti, C. Fenoglio, L. Bonanni, 2021, Journal of Alzheimer's disease reports.

Language impairment in the genetic forms of behavioural variant frontotemporal dementia

Jennifer M. Nicholas, M. Freedman, R. Keren, 2022, Journal of Neurology.

A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study

Jennifer M. Nicholas, M. Freedman, S. Ourselin, 2021, Molecular Neurodegeneration.

P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis

N. Bresolin, D. Galimberti, C. Fenoglio, 2005, Neuroscience Letters.

Genetics and epigenetics: Basic concepts

C. Fenoglio, 2014 .

Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease

N. Bresolin, D. Galimberti, C. Fenoglio, 2009, Journal of the Neurological Sciences.

Immunoproteasome LMP2 60HH Variant Alters MBP Epitope Generation and Reduces the Risk to Develop Multiple Sclerosis in Italian Female Population

Sandra D'Alfonso, Filippo Martinelli-Boneschi, Claudio Franceschi, 2010, PloS one.

Novel exon 1 progranulin gene variant in Alzheimer’s disease

N. Bresolin, S. Cappa, F. Clerici, 2008, European journal of neurology.

Anti-Cholinergic Derangement of Cortical Metabolism on 18F-FDG PET in a Patient with Frontotemporal Lobar Degeneration Dementia: A Case of the TREDEM Registry.

D. Galimberti, C. Fenoglio, L. Bonanni, 2020, Journal of Alzheimer's disease : JAD.

Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis

D. Galimberti, C. Fenoglio, E. Scarpini, 2013, International journal of molecular sciences.

Rapidly progressive primary progressive aphasia and parkinsonism with novel GRN mutation

B. Ghetti, D. Galimberti, C. Fenoglio, 2017, Movement Disorders.

Theme 08 - Clinical Imaging and Electrophysiology

Jennifer M. Nicholas, M. Freedman, R. Keren, 2022, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition.

D. Galimberti, C. Fenoglio, E. Scarpini, 2021, Journal of Alzheimer's disease : JAD.

Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degeneration

N. Bresolin, S. Cappa, D. Mari, 2013, Neurological Sciences.

Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome.

D. Galimberti, C. Fenoglio, E. Scarpini, 2020, Journal of Alzheimer's disease : JAD.

Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer's Disease Patients.

D. Galimberti, C. Fenoglio, E. Scarpini, 2018, Journal of Alzheimer's disease : JAD.

Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage

M. Bozzali, D. Galimberti, C. Fenoglio, 2022, Alzheimer's research & therapy.

Polymorphisms in the LOC387715/ARMS2 Putative Gene and the Risk for Alzheimer’s Disease

D. Galimberti, C. Fenoglio, E. Venturelli, 2008, Dementia and Geriatric Cognitive Disorders.

DCUN1D1 is a risk factor for frontotemporal lobar degeneration

N. Bresolin, S. Cappa, F. Clerici, 2009, European journal of neurology.

The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration

N. Bresolin, S. Cappa, F. Clerici, 2009, European journal of neurology.

The T-786C NOS3 polymorphism in Alzheimer's disease: Association and influence on gene expression

N. Bresolin, C. Mariani, D. Galimberti, 2005, Neuroscience Letters.

Association of neuronal nitric oxide synthase C276T polymorphism with Alzheimer’s disease

N. Bresolin, C. Mariani, D. Galimberti, 2005, Journal of Neurology.

Is HCRTR2 a Genetic Risk Factor for Alzheimer's Disease?

D. Galimberti, C. Fenoglio, E. Scarpini, 2014, Dementia and Geriatric Cognitive Disorders.

Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?

D. Galimberti, C. Fenoglio, E. Scarpini, 2019, Journal of Alzheimer's disease : JAD.

Candidate gene analysis of semaphorins in patients with Alzheimer’s disease

N. Bresolin, D. Galimberti, C. Fenoglio, 2010, Neurological Sciences.

THE ROLE OF CELLULAR AND EXOSOMAL NEURAL-DERIVED LONG NON CODING RNA (LNCRNA) IN MULTIPLE SCLEROSIS: POTENTIAL BIOMARKERS OF DISEASE SUSCEPTIBILITY AND PROGRESSION

C. Fenoglio, E. Scarpini, R. Ghidoni, 2018 .

CXCR4 involvement in neurodegenerative diseases

O. Andreassen, G. Schellenberg, A. Dale, 2017, bioRxiv.

Identification of a sex-specific genetic signature in dementia with Lewy bodies: a meta-analysis of genome-wide association studies

John X. Morris, Elisabet, Sonja W. Scholz, 2022, medRxiv.

Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2022, Journal of Neuroinflammation.

Association study to evaluate the serotonin transporter and apolipoprotein E genes in frontotemporal lobar degeneration in Italy

L. Polito, C. Mariani, D. Galimberti, 2008, Journal of Human Genetics.

Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients

N. Bresolin, G. Comi, C. Mariani, 2005, Neurobiology of Aging.

Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay

Nick C Fox, J. Schott, K. Bhatia, 2016, Molecular Neurodegeneration.

Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes

D. Galimberti, C. Fenoglio, E. Scarpini, 2019, Alzheimer's Research & Therapy.

Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

Jennifer M. Nicholas, M. Freedman, R. Keren, 2023, Journal of the Neurological Sciences.

Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

P. Pietrini, R. Desikan, J. Trojanowski, 2019, Scientific Reports.

Vascular endothelial growth factor gene variability is associated with increased risk for AD

S. Ghezzi, N. Bresolin, G. Comi, 2005, Journal of the Neurological Sciences.

Klotho Gene Expression Is Decreased in Peripheral Blood Mononuclear Cells in Patients with Alzheimer's Disease and Frontotemporal Dementia.

D. Galimberti, C. Fenoglio, E. Scarpini, 2023, Journal of Alzheimer's disease : JAD.

No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis

N. Bresolin, G. Comi, X. Montalban, 2014, Journal of Neuroimmunology.

CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients.

M. Franceschi, G. Comi, G. Magnani, 2016, Journal of Alzheimer's disease : JAD.

Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis

D. Galimberti, C. Fenoglio, E. Scarpini, 2016, Journal of Neuroimmunology.

Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status.

D. Galimberti, C. Fenoglio, E. Scarpini, 2023, European journal of neurology.

Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation

M. Filippi, M. Franceschi, F. Agosta, 2013, Biological Psychiatry.

Vascular endothelial growth factor gene variability is associated with increased risk for AD

D. Galimberti, C. Fenoglio, E. Scarpini, 2005, Annals of neurology.

CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia

D. Galimberti, J. Rohrer, C. Fenoglio, 2018, Neurobiology of Aging.

Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred.

N. Bresolin, D. Galimberti, C. Fenoglio, 2011, Journal of Alzheimer's disease : JAD.

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Nick C Fox, Pavel P. Kuksa, W. M. van der Flier, 2022, Nature Genetics.

Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer’s Disease

D. Galimberti, C. Fenoglio, E. Scarpini, 2023, International journal of molecular sciences.

Circulating miRNAs as potential biomarkers in Alzheimer’s disease

D. Galimberti, C. Fenoglio, E. Scarpini, 2013 .

Diagnostic accuracy of research criteria for prodromal frontotemporal dementia

Y. Pijnenburg, T. Rittman, B. Nacmias, 2024, Alzheimer's Research & Therapy.